Constructing classification boundaries in the memory clinic: negotiating risk and uncertainty in constituting mild

Julia Swallow1

  • 1School of Sociology and Social Policy, University of Leeds, Leeds, UK.

Insights

Distinguishing normal aging from Alzheimer's disease (AD) and mild cognitive impairment (MCI) is complex. Clinicians manage diagnostic uncertainty for MCI patients, balancing risk assessment with the difficulty of predicting future Alzheimer's progression.

Area of Science:

  • Gerontology
  • Neurology
  • Sociology of Health and Illness

Background:

  • Differentiating normal aging from pathological cognitive decline, such as Alzheimer's disease (AD), is challenging.
  • Mild cognitive impairment (MCI) is a diagnostic category for individuals at risk of AD, but progression is uncertain.
  • Clinical practice involves complex boundary-making between normal aging, MCI, and AD.

Purpose of the Study:

  • To examine how healthcare practitioners construct diagnostic boundaries for MCI and AD in outpatient memory clinics.
  • To understand how uncertainty is managed in the classification of cognitive deterioration.
  • To explore the social and political contexts influencing the management of aging and cognitive decline.

Main Methods:

  • Qualitative data collection from an outpatient memory service.
  • Analysis of practitioners' accounts and clinical decision-making processes.
  • Examination of how diagnostic categories are constructed and negotiated.

Main Results:

  • Practitioners utilize the MCI classification to manage diagnostic uncertainty, enabling patient review for potential AD development.
  • There is a recognized difficulty in accurately predicting future progression from MCI to AD.
  • Classification decisions are influenced by both clinical uncertainty and broader socio-political factors related to aging and cognitive health.

Conclusions:

  • The diagnosis and management of MCI involve navigating significant clinical uncertainty regarding future Alzheimer's disease risk.
  • Practitioners' classification practices reflect a complex interplay between managing individual patient risk and broader societal perceptions of aging and cognitive health.
  • Understanding these boundary-making processes is crucial for effective clinical care and policy development in dementia and aging.

Related Concept Videos

Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
469
Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.5K
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
714
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K